Key result
Atropine sulfate links to reduced ECT-induced QTc prolongation, potentially lowering ventricular arrhythmia risk.
Why the study?
Does atropine sulfate reduce QTc prolongation induced by electroconvulsive therapy in patients with depression?
Observational (n=32)
Does atropine sulfate reduce QTc prolongation induced by electroconvulsive therapy in patients with depression?
Atropine sulfate may reduce the risk of ventricular arrhythmias, including Torsade de Pointes, by mitigating QTc prolongation induced by electroconvulsive therapy.
Supports atropine for reducing ECT-induced QTc prolongation; hypothesis-generating observational data require randomized trials to confirm arrhythmia benefit.
BACKGROUND: Electrocardiogram abnormalities have been reported during electroconvulsive therapy (ECT). A corrected QT interval (QTc) prolongation indicates delayed ventricular repolarization, which can trigger ventricular arrhythmias such as torsade de pointes (TdP). We examined the QTc changes during generalized tonic-clonic seizures induced by ECT, and the effects of atropine sulfate on these QTc changes. METHODS: We analyzed heart rate, QT interval, and QTc in 32 patients with depression who underwent ECT (25 women, 67.4 ± 8.7 years of age). The QTc from -30 to 0 seconds prestimulation was used as baseline, which was compared with QTc at 20-30 seconds and 140-150 seconds poststimulus onset. RESULTS: QTc was significantly prolonged at 20-30 seconds poststimulus, then significantly decreased at 140-150 seconds poststimulus, compared with baseline. QTc prolongation induced by ECT was significantly decreased by atropine sulfate. CONCLUSIONS: These data suggest that the risk of TdP may be enhanced by ECT. Further, the risk of cardiac ventricular arrhythmias, including TdP, may be reduced by administration of atropine sulfate.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2017) conducted an observational in Depression undergoing electroconvulsive therapy (n=32). Atropine sulfate vs. Baseline (prestimulation) was evaluated on QTc changes during generalized tonic-clonic seizures induced by ECT. Atropine sulfate significantly decreased the QTc prolongation induced by electroconvulsive therapy in patients with depression, potentially reducing the risk of ventricular arrhythmias.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: